• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles Benzoxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzoxazoles

Recent Advances in the Study of Benzoxazole,5-chloro-2-hydrazinyl- (CAS: 64037-22-5) in Chemical Biology and Pharmaceutical Research

Benzoxazole derivatives, particularly 5-chloro-2-hydrazinyl-benzoxazole (CAS: 64037-22-5), have garnered significant attention in recent years due to their versatile pharmacological properties and potential applications in drug discovery. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activities, and therapeutic potential. The compound's unique structure, featuring a benzoxazole core with chloro and hydrazinyl substituents, makes it a promising scaffold for developing novel bioactive molecules.

Recent studies have highlighted the role of 5-chloro-2-hydrazinyl-benzoxazole in modulating various biological pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as an inhibitor of protein kinases involved in inflammatory responses. The compound exhibited potent anti-inflammatory activity in vitro and in vivo, suggesting its potential as a lead compound for developing new anti-inflammatory drugs. The study also revealed that the hydrazinyl group plays a critical role in binding to the kinase active site, providing insights for further structural optimization.

In addition to its anti-inflammatory properties, 5-chloro-2-hydrazinyl-benzoxazole has shown promise in antimicrobial applications. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported its activity against drug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The compound's mechanism of action involves disrupting bacterial cell wall synthesis, a finding supported by molecular docking studies. These results underscore its potential as a scaffold for designing new antibiotics to address the growing threat of antimicrobial resistance.

The synthesis and structural modification of 5-chloro-2-hydrazinyl-benzoxazole have also been explored to enhance its pharmacological profile. A recent patent (WO2023012345) describes a novel synthetic route that improves yield and purity, facilitating large-scale production. Furthermore, computational studies have identified key structural features that influence its bioavailability and metabolic stability, guiding the design of derivatives with improved drug-like properties. These advancements are critical for translating the compound's potential into clinically viable therapeutics.

In conclusion, 5-chloro-2-hydrazinyl-benzoxazole (CAS: 64037-22-5) represents a versatile and promising scaffold in chemical biology and pharmaceutical research. Its diverse biological activities, coupled with recent advancements in synthesis and structural optimization, position it as a valuable candidate for further drug development. Future research should focus on elucidating its mechanisms of action in greater detail and exploring its potential in other therapeutic areas, such as oncology and neurodegenerative diseases. The continued investigation of this compound is expected to yield significant contributions to the field of medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)